| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.040 | 58.140 | 119.071 | 109.850 | 51.318 | - | - | - | - |
| Total Income - EUR | - | 4.042 | 58.140 | 119.071 | 109.850 | 51.318 | - | - | - | - |
| Total Expenses - EUR | - | 23.651 | 50.453 | 102.808 | 129.506 | 56.175 | - | - | - | - |
| Gross Profit/Loss - EUR | - | -19.610 | 7.687 | 16.263 | -19.655 | -4.857 | - | - | - | - |
| Net Profit/Loss - EUR | - | -19.701 | 7.111 | 15.072 | -20.754 | -5.329 | - | - | - | - |
| Employees | - | 1 | 2 | 3 | 4 | 3 | - | - | - | - |
Check the financial reports for the company - Neuropain Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 34.622 | 55.580 | 57.218 | 55.053 | 52.972 | - | - | - | - |
| Current Assets | - | 9.802 | 11.225 | 21.704 | 26.704 | 29.673 | - | - | - | - |
| Inventories | - | 4.075 | 4.424 | 6.523 | 6.850 | 6.720 | - | - | - | - |
| Receivables | - | 995 | 979 | 12.748 | 17.961 | 21.620 | - | - | - | - |
| Cash | - | 4.732 | 5.823 | 2.432 | 1.893 | 1.333 | - | - | - | - |
| Shareholders Funds | - | -19.656 | -12.213 | 3.083 | -17.730 | -23.882 | - | - | - | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | - | 64.080 | 79.018 | 75.838 | 99.487 | 106.526 | - | - | - | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Neuropain Srl